Biogen Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 578.6 million compared to USD 699.7 million a year ago. Revenue was USD 2,290.5 million compared to USD 2,463 million a year ago.

Net income was USD 393.4 million compared to USD 387.9 million a year ago. Basic earnings per share from continuing operations was USD 2.71 compared to USD 2.69 a year ago. Diluted earnings per share from continuing operations was USD 2.7 compared to USD 2.67 a year ago.